(C) World Health Organization
This story was originally published by World Health Organization and is unaltered.
. . . . . . . . . .
Webinar – New WHO Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable PrEP [1]
[]
Date: 2025-08-28
This 60-minute webinar is intended for communities, providers, policy makers and advocates interested in pre-exposure prophylaxis (PrEP), HIV prevention and HIV testing. We will provide an overview of the key takeaways and guidance from the newly released WHO Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. We also touch on some of the key issues and upcoming plans for lenacapavir implementation.
Objectives
By the end of the webinar, attendees will clearly understand the new WHO recommendations on lenacapavir, the supporting evidence, key implementation considerations, and evidence gaps, empowering them to drive advocacy and informed decisions on the introduction of lenacapavir in countries.
Date and time
Thursday, 28 August 2025
13:00 – 14:00 CEST
Speakers
Chair: Michelle Rodolph, WHO headquarters
Carlota Baptista da Silva, WHO headquarters
Lloyd Mulenga, Ministry of Health, Zambia
Danvic Rosadino, Love Yourself, Philippines
Heather-Marie Schmidt, UNAIDS
Hasina Subedar, National Department of Health, South Africa
Olakunle Taiwo, Ministry of Health, Nigeria
Webinar series
This is the first webinar in a three-part series:
Part 2 on 4 September 2025 will focus on HIV testing.
Part 3 will focus on e-training for PrEP providers.
Further details about these webinars will be shared soon.
[END]
---
[1] Url:
https://www.who.int/news-room/events/detail/2025/08/28/default-calendar/webinar-new-who-guidance-on-lenacapavir-for-prevention-and-hiv-testing-for-long-acting-prep
Published and (C) by World Health Organization
Content appears here under this condition or license: Creative Commons CC-BY-NC-SA 3.0 IGO.
via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/who/